Annual Total Liabilities
$99.07 M
+$39.62 M+66.65%
December 31, 2024
Summary
- As of March 13, 2025, ALGS annual total liabilities is $99.07 million, with the most recent change of +$39.62 million (+66.65%) on December 31, 2024.
- During the last 3 years, ALGS annual total liabilities has risen by +$48.43 million (+95.64%).
- ALGS annual total liabilities is now -53.14% below its all-time high of $211.41 million, reached on December 31, 2019.
Performance
ALGS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$99.07 M
+$60.74 M+158.46%
December 31, 2024
Summary
- As of March 13, 2025, ALGS quarterly total liabilities is $99.07 million, with the most recent change of +$60.74 million (+158.46%) on December 31, 2024.
- Over the past year, ALGS quarterly total liabilities has increased by +$60.74 million (+158.46%).
- ALGS quarterly total liabilities is now -56.71% below its all-time high of $228.85 million, reached on September 30, 2020.
Performance
ALGS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ALGS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +66.7% | +158.5% |
| 3 y3 years | +95.6% | +167.8% |
| 5 y5 years | -53.1% | +167.8% |
ALGS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +131.5% | at high | +219.3% |
| 5 y | 5-year | -53.1% | +131.5% | -56.7% | +270.8% |
| alltime | all time | -53.1% | +131.5% | -56.7% | +270.8% |
Aligos Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $99.07 M(+66.6%) | $99.07 M(+158.5%) |
| Sep 2024 | - | $38.33 M(-7.8%) |
| Jun 2024 | - | $41.58 M(-38.9%) |
| Mar 2024 | - | $68.11 M(+14.6%) |
| Dec 2023 | $59.45 M(+38.9%) | $59.45 M(+91.6%) |
| Sep 2023 | - | $31.03 M(-15.0%) |
| Jun 2023 | - | $36.49 M(-1.3%) |
| Mar 2023 | - | $36.99 M(-13.6%) |
| Dec 2022 | $42.79 M | $42.79 M(+1.8%) |
| Sep 2022 | - | $42.06 M(-7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $45.54 M(-20.9%) |
| Mar 2022 | - | $57.58 M(+13.7%) |
| Dec 2021 | $50.64 M(+11.9%) | $50.64 M(+9.9%) |
| Sep 2021 | - | $46.06 M(+7.1%) |
| Jun 2021 | - | $42.99 M(+9.3%) |
| Mar 2021 | - | $39.32 M(-13.1%) |
| Dec 2020 | $45.26 M(-78.6%) | $45.26 M(-80.2%) |
| Sep 2020 | - | $228.85 M(+756.5%) |
| Jun 2020 | - | $26.72 M(-87.4%) |
| Dec 2019 | $211.41 M(+74.0%) | $211.41 M |
| Dec 2018 | $121.48 M | - |
FAQ
- What is Aligos Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Aligos Therapeutics?
- What is Aligos Therapeutics annual total liabilities year-on-year change?
- What is Aligos Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly total liabilities year-on-year change?
What is Aligos Therapeutics annual total liabilities?
The current annual total liabilities of ALGS is $99.07 M
What is the all time high annual total liabilities for Aligos Therapeutics?
Aligos Therapeutics all-time high annual total liabilities is $211.41 M
What is Aligos Therapeutics annual total liabilities year-on-year change?
Over the past year, ALGS annual total liabilities has changed by +$39.62 M (+66.65%)
What is Aligos Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ALGS is $99.07 M
What is the all time high quarterly total liabilities for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly total liabilities is $228.85 M
What is Aligos Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ALGS quarterly total liabilities has changed by +$60.74 M (+158.46%)